Leadership: Dan L Duncan Comprehensive Cancer Center
C Kent Osborne, M.D.
- (713) 798-1999
Diagnosis and treatment of breast cancer; Biology of breast cancer; Resistance to ER and HER2-targeted therapies in breast cancer…
David G Poplack, M.D.
- (832) 822-4556
Childhood leukemia; Cancer survivorship; Clinical pharmacology of anticancer agents in children
Melissa L. Bondy, Ph.D., M.S.
- (713) 798-2953
Malcolm K Brenner, M.D., Ph.D.
- (832) 824-4671
Use of gene therapy to improve responses to cancer
Steven Curley, M.D.
- Professor of Surgery and Chief
Nancy Jo Davis, B.A.
- Sr Director, Development
Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP
- Professor / Director
- (713) 798-1999
Breast Cancer Oncology; Breast Cancer Genomics; Metastatic Breast Cancer; Clinical Trials
Suzanne A W Fuqua, Ph.D.
- (713) 798-1671
Breast cancer; Hormone receptors, hormone responsiveness, gene expression profiling, mutant ER, metastasis, predictive markers
Helen E Heslop, MD, DSc (Hon)
- (832) 824-4662
Cell and Gene Therapy
Susan Galloway Hilsenbeck, Ph.D.
- (713) 798-1627
Design and statistical analysis of translational experiments and clinical trials
Maria L Jibaja-Weiss, M.Ed., Ed.D.
- Director - Office of Outreach and Health Disparities
- (713) 798-3636
Martha Pritchett Mims, M.D., Ph.D.
- Professor and Chief
- (713) 798-7535
Dr. Martha Mims treats patients with hematologic malignancies and solid tumors.
Bert W O'Malley, M.D.
- (713) 798-6205
Hormone action; Coactivator function; Eukaryotic gene expression; Gene therapy; Nanotechnology
Theodore J Yank, M.H.A.
- Associate Director for Administration
- (713) 798-9045
Jason T. Yustein
- (832) 824-4601